Unknown

Dataset Information

0

Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.


ABSTRACT:

Objectives

The prevalence of obesity with sarcopenia is increasing in adults aged ≥65 years. This geriatric syndrome places individuals at risk for synergistic complications that leads to long-term functional decline. We ascertained the relationship between sarcopenic obesity and incident long-term impaired global cognitive function in a representative US population.

Design

A longitudinal, secondary data set analysis using the National Health and Aging Trends Survey.

Setting

Community-based older adults in the United States.

Participants

Participants without baseline impaired cognitive function aged ≥65 years with grip strength and body mass index measures.

Methods

Sarcopenia was defined using the Foundation for the National Institutes of Health Sarcopenia Project grip strength cut points (men <35.5 kg; women <20 kg), and obesity was defined using standard body mass index (BMI) categories. Impaired global cognition was identified as impairment in the Alzheimer's Disease-8 score or immediate/delayed recall, orientation, clock-draw test, date/person recall. Proportional hazard models ascertained the risk of impaired cognitive function over 8 years (referent = neither obesity or sarcopenia).

Results

Of the 5822 participants (55.7% women), median age category was 75 to 80, and mean grip strength and BMI were 26.4 kg and 27.5 kg/m2, respectively. Baseline prevalence of sarcopenic obesity was 12.9%, with an observed subset of 21.2% participants having impaired cognitive function at follow-up. Compared with those without sarcopenia or obesity, the risk of impaired cognitive function was no different in obesity alone [hazard ratio (HR) 0.98; 95% confidence interval (CI) 0.82-1.16]), but was significantly higher in sarcopenia (HR 1.60; 95% CI 1.42-1.80) and sarcopenic obesity (HR 1.20; 95% CI 1.03-1.40). There was no significant interaction term between sarcopenia and obesity.

Conclusions

Both sarcopenia and sarcopenic obesity are associated with an increased long-term risk of impaired cognitive function in older adults.

SUBMITTER: Batsis JA 

PROVIDER: S-EPMC8269419 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.

Batsis John A JA   Haudenschild Christian C   Roth Robert M RM   Gooding Tyler L TL   Roderka Meredith N MN   Masterson Travis T   Brand John J   Lohman Matthew C MC   Mackenzie Todd A TA  

Journal of the American Medical Directors Association 20201021 4


<h4>Objectives</h4>The prevalence of obesity with sarcopenia is increasing in adults aged ≥65 years. This geriatric syndrome places individuals at risk for synergistic complications that leads to long-term functional decline. We ascertained the relationship between sarcopenic obesity and incident long-term impaired global cognitive function in a representative US population.<h4>Design</h4>A longitudinal, secondary data set analysis using the National Health and Aging Trends Survey.<h4>Setting</h  ...[more]

Similar Datasets

| S-EPMC9975009 | biostudies-literature
| PRJNA1265386 | ENA
| PRJNA1265387 | ENA
| S-EPMC10869697 | biostudies-literature
| S-EPMC9254413 | biostudies-literature
| S-EPMC10094434 | biostudies-literature
| S-EPMC11449331 | biostudies-literature
| S-EPMC9992327 | biostudies-literature
| S-EPMC10888391 | biostudies-literature
| S-EPMC6812624 | biostudies-literature